LETHAM, Scotland, Aug. 13, 2024 /PRNewswire/ — MDJM LTD (Nasdaq: MDJH) (the “Company” or “MDJM”), an integrated global culture-driven asset management company, announced today the appointment of Dr. Pei-Kai Cheng to the Expert Committee of its wholly owned subsidiary, MD Local Global Limited, a United Kingdom Company. Dr. Cheng’s involvement marks a significant enhancement to […]
Category Archives: Pr Newswire
OXFORD, England, Aug. 13, 2024 /PRNewswire/ — Unipart, the supply chain solutions and performance improvement technologies partner, has announced the acquisition of the former Schaeffler Rail Bearing reconditioning business in Auburn, New South Wales. Mark Carling, Unipart Rail Australia & Asia Pacific Managing Director The acquisition was completed on 12 August 2024, transferring the business […]
DUBAI, UAE, Aug. 13, 2024 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial and Operating Highlights Revenues were US$81.2 million in the second […]
Pr Newswire
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
12
Aug
Aug
Presented cohort one (low dose) data from both trials of TSHA-102 at 2024 IRSF Rett Syndrome Scientific Meeting that demonstrated durable improvements across consistent clinical domains and an encouraging safety profile in adult (up to 52 weeks) and pediatric (up to 22 weeks) patients TSHA-102 was generally well tolerated with no SAEs or DLTs as […]
Pr Newswire
MBX Biosciences Doses First Patient in Phase 2 Avail™ Trial of MBX 2109 for the Treatment of Hypoparathyroidism
12
Aug
Aug
Topline results expected in Q3 2025 CARMEL, Ind., Aug. 12, 2024 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that it has dosed the first patient in its Phase 2 Avail™ […]
Pr Newswire
ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer
12
Aug
Aug
First-line monotherapy data for once daily firmonertinib selected as an oral presentation in the presidential session First prospectively designed randomized clinical data for a small-molecule EGFR tyrosine kinase inhibitor in PACC mutant non-small cell lung cancer patient population ArriVent to host virtual webinar in conjunction with 2024 WCLC NEWTOWN SQUARE, Pa., Aug. 12, 2024 (GLOBE […]
Pr Newswire
LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
12
Aug
Aug
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first and only aceclidine-based eye drop to improve near vision in people with presbyopia, today announced that the Company has submitted a New Drug Application (NDA) to U.S. […]
12
Aug
Aug
EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced that management will participate in a fireside chat at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference. Members of the […]
PALO ALTO, Calif., Aug. 12, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that FlexTV, its short drama streaming platform, has ranked No.3 in the App Store Entertainment Chart (Free Apps, Indonesia) and Google Play Entertainment App (Free Apps, Indonesia) as of August 12, 2024. This accomplishment further solidifies […]
SHANGHAI, Aug. 12, 2024 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced it plans to release its unaudited financial results for the second quarter of 2024 ended June 30, 2024 before U.S. markets open on Monday, […]